Articles From: CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Merck & Co., Inc. to Curis Reports Third Quarter 2014 Financial Results and Pipeline Update


2014/12/8
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Cubist Pharmaceuticals, Inc. (“Cubist”) (NASDAQ GS:CBST) concerning the sale to Merck & Co., Inc. Under the terms of the agreement, Cubist shareholders will receive $102.00 in cash for each share owned, which is only a 37% premium over the share price just before the deal was announced and only a slight premium over the 52-week high.
Sign-up for CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Merck & Co., Inc. investment picks
2014/12/11
Rigrodsky & Long, P.A.: Do you own shares of Cubist Pharmaceuticals, Inc. (NASDAQ GS: CBST )? Did you purchase any of your shares prior to December 8, 2014?
Sign-up for CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2014/12/8
WILMINGTON, Del.
Sign-up for CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Michael Tomsicek, Cubist’s SVP & Chief Financial Officer, will present at the Jefferies 2014 Healthcare Conference on Wednesday, November 19, to discuss the company’s business activities, financial outlook, and current news.
Sign-up for Cubist to Present at Jefferies 2014 Healthcare Conference investment picks
TUALATIN, Ore.
Sign-up for CUI Global Reports Unaudited Third Quarter 2014 Financial Results investment picks
TUALATIN, Ore.
Sign-up for CUI Global, Inc. To Ring The NASDAQ Stock Market Closing Bell investment picks
Cullen Agricultural Holding Corp.
Sign-up for Cullen Agricultural Holding Corp. and Long Island Brand Beverages LLC Agree to Merge investment picks
2014/10/30
SAN ANTONIO , Oct.
Sign-up for Cullen/Frost Bankers Declares Quarterly Cash Dividend For Common Stock And Preferred Stock investment picks
SAN ANTONIO, Texas , Jan.
Sign-up for Cullen/Frost Bankers, Inc. Hosts Fourth Quarter and Annual 2014 Earnings Conference Call investment picks
- Average loans increase 14.7 percent - Average deposits rise 16.9 percent - Asset quality continues to improve SAN ANTONIO , Oct.
Sign-up for Cullen/Frost Reports Strong Third Quarter Results investment picks
Culp, Inc. (NYSE: CFI) today reported financial and operating results for the second quarter and six months ended November 2, 2014.
Sign-up for Culp Announces Results for Second Quarter Fiscal 2015 investment picks
Culp, Inc. (NYSE: CFI), today announced that it will provide an online, real-time webcast and rebroadcast of its fiscal 2015 second quarter conference call on Thursday, December 4, 2014, at 11:00 a.m. ET.
Sign-up for Culp, Inc. to Broadcast Fiscal 2015 Second Quarter Conference Call Live on the Internet investment picks
http://media.marketwire.com/attachments/201211/98749_netapp.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153636&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Culture of Trust Earns NetApp #3 Best Place to Work in the World investment picks
- Revenues up nearly 50% from prior year period NASHVILLE, Tenn.
Sign-up for Cumberland Pharmaceuticals Reports Third Quarter 2014 Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G030985-001&sourceType=1 http://www.marketwire.com/library/MwGo/2015/1/21/11G030985/88f2119c26390786_org-946977796.jpg COLUMBUS, IN--(Marketwired - January 21, 2015) - Cummins Inc. (NYSE: CMI) today announced that Tony Satterthwaite, Vice President, President - Cummins Power Generation, will become President of the Company's Distribution Business Unit, succeeding Vice President and President Pamela Carter who is retiring.
Sign-up for Cummins Announces Leadership Changes investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G030776-001&sourceType=1 http://www.marketwire.com/library/MwGo/2015/1/19/11G030776/b8fe6fb43432e22b_org-1241178466.jpg COLUMBUS, IN--(Marketwired - January 19, 2015) - Cummins Inc. (NYSE: CMI) today announced that Distribution Business President Pamela Carter, the first woman to lead one of the Company's four main business units, is retiring effective April 1.
Sign-up for Cummins Announces Pamela Carter Retiring After Pioneering Career investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026608-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/17/11G026608/88151fa038d1f3b6_org-828593777.jpg COLUMBUS, IN--(Marketwired - November 17, 2014) - Cummins Inc. (NYSE: CMI) today named Tracy Embree President of the Components Group, effective January 1.
Sign-up for Cummins Inc. Names Tracy Embree President, Components Group investment picks
CHARLESTON, S.C. , Nov.
Sign-up for Cummins Launches QSK50 Optimized for Variable Speed Diesel Electric Applications investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G024701-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/27/11G024701/b9b55343545cc417_org-950798688.jpg COLUMBUS, IN--(Marketwired - October 28, 2014) - Cummins Inc. (NYSE: CMI) today reported results for the third quarter of 2014.
Sign-up for Cummins Reports Strong Results for the Third Quarter of 2014 investment picks
ATLANTA, Nov.
Sign-up for Cumulus Reports Operating Results for Third Quarter 2014 investment picks
CureDuchenne and Prosensa Holding N.V. (NASDAQ: RNA) have been selected to present at the 6 th annual Partnering for Cures , November 16-18 in New York City.
Sign-up for Cure Duchenne and Prosensa to Present Collaboration at Partnering for Cures Conference investment picks
ELK GROVE VILLAGE, Ill.
Sign-up for Cure SMA Presents Isis Pharmaceuticals with SMA Breakthrough Award investment picks
-- Agreement Provides Curis with Option to Exclusively License Aurigene's Antagonists for Immuno-Oncology, Including an Antagonist of PD-L1 and Selected Precision Oncology Targets, Including an IRAK4 Kinase Inhibitor --
Sign-up for Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-Oncology and Precision Oncology Targets investment picks
-- Curis Provides Summary From Dose Escalation Stage of CUDC-907 Phase 1 Study Supporting Ongoing Expansion in DLBCL Patients – LEXINGTON, Mass., Nov.
Sign-up for Curis Reports Third Quarter 2014 Financial Results and Pipeline Update investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Merck & Co., Inc. to Curis Reports Third Quarter 2014 Financial Results and Pipeline Update
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent